Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- Nature Careers
- SciLifeLab
- ;
- Heidelberg University
- Leibniz
- University of Oslo
- Columbia University
- Cranfield University
- Curtin University
- DAAD
- La Trobe University
- Leiden University
- Nencki Institute of Experimental Biology PAS
- Rutgers University
- The University of Chicago
- University of Kansas Medical Center
- University of Miami
- University of Utah
- VIB
- ; Bangor University
- ; Newcastle University
- ; Swansea University
- ; University of Bradford
- ; University of Hertfordshire
- ; University of Surrey
- ; University of Sussex
- AALTO UNIVERSITY
- Arizona State University
- CWI
- Duke University
- Erasmus University Rotterdam
- Fred Hutchinson Cancer Center
- German Cancer Research Center (DKFZ) Heidelberg •
- Imperial College London
- MASARYK UNIVERSITY
- OsloMet
- Technical University of Denmark
- Technical University of Munich
- The University of Iowa
- UiT The Arctic University of Norway
- University of Antwerp
- University of Bergen
- University of Cambridge
- University of Duisburg-Essen •
- University of Groningen
- University of Michigan
- University of Minnesota
- University of Oxford
- University of Pittsburgh
- University of Southern Denmark
- Yeshiva University
- 41 more »
- « less
-
Field
-
to the start of employment, applicants must: 1) hold a Ph.D. degree in cancer biology, immunology, or a related field and 2) have completed postdoctoral training. To be considered, those interested must apply
-
well as innovation and commercialization projects. More about the position The candidate will work on a project to develop extracellular vesicles (EVs) from NK cells as nanovehicles for cancer therapy. NK cells
-
strategies. We develop new methods with which tumors can be diagnosed more precisely and cancer patients can be treated more successfully. Every contribution counts – whether in research, administration
-
cancer cell plasticity in AML. Our overall goal is to pave the way for new cancer therapies. The aim of this PhD position is to perform and to functionally and molecularly characterize multiomics single
-
diagnosis, and therapy of diseases like cardiovascular diseases or cancer. Overall, the institute strives to advance precision medicine by combining knowledge from different fields such as biology, chemistry
-
the mechanisms and develop innovative therapies and diagnostic methods for cancer, diabetes, neurodegenerative diseases, neurological disorders and other civilization diseases. In addition to basic biological
-
, showing potential to treat various cancers. The aim of this project is to use a multidisciplinary approach involving (bio)chemistry, computer aided drug design, cell biology and genetics to develop more
-
Commission under the Horizon Europe framework program. NUCLEAR brings together European leaders in the fields of metabolomics, functional genomics, chromatin regulation, stem cell biology, and cancer with